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Neutralization of Nogo-A enhances synaptic plasticity in the 
rat motor cortex and improves motor learning in-vivo. 
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ABSTRACT  
 
150 words 
 
The membrane protein Nogo-A has been well described as an inhibitor of 
axonal outgrowth and central nervous system (CNS) regeneration, whereas 
its physiological functions remain less well characterized. Here, we 
investigated the role of Nogo-A on cortical synaptic plasticity and motor 
learning in the uninjured CNS. We identified synaptic location of Nogo-A and 
its receptor NgR1 in the motor cortex (M1) and showed that treatment with 
antibodies against Nogo-A and its receptor increased long-term potentiation of 
layer 2/3 horizontal fibers. Furthermore, Nogo-A antibody treatment promoted 
synaptogenesis of pyramidal neurons in M1, as revealed by in vivo two-
photon microscopy. More importantly, improved motor learning in rats upon 
anti-Nogo treatment correlates the changes in synaptic plasticity. Together, 
our findings reveal a novel role for Nogo-A. It acts as a negative regulator of 
activity-dependent functional and structural synaptic plasticity in the motor 
cortex and a crucial factor for motor learning.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
Introduction, results, discussion 2000 - 4000 words 
 
Functional synaptic plasticity describes the ability of excitatory synapses to 
undergo activity-driven long lasting changes in the efficacy of synaptic 
transmission. This change may be expressed as long-term potentiation (LTP) 
or long-term depression (LTD) and correlates with structural modifications at 
dendritic spines (Yu and Zuo 2011). Both functional and structural synaptic 
plasticity have been suggested to serve as underlying mechanisms for 
learning and memory in several regions of the brain (Marr 1969; Morris, 
Anderson et al. 1986; Ito 2001; Kandel 2001; Whitlock, Heynen et al. 2006; 
Holtmaat and Svoboda 2009; Yang, Pan et al. 2009), including acquisition of 
novel motor skills (Rioult-Pedotti, Friedman et al. 1998; Rioult-Pedotti, 
Friedman et al. 2000; Harms, Rioult-Pedotti et al. 2008; Xu, Yu et al. 2009; 
Fu, Yu et al. 2012). 
 
The membrane protein Nogo-A has originally been identified as a myelin-
derived neurite outgrowth inhibitor in the adult CNS (Caroni and Schwab 
1988). Neutralization of Nogo-A, Nogo Receptor 1 (NgR1) or inhibition of the 
downstream signaling cascades via RhoA and Rho-associated protein kinase 
(ROCK) enhances regenerative and compensatory fiber growth and improves 
functional recovery after CNS injury or stroke (Schnell and Schwab 1990; 
Chen, Huber et al. 2000; GrandPre, Li et al. 2002; Fournier, Takizawa et al. 
2003; Kim, Liu et al. 2004; Liebscher, Schnell et al. 2005; Gonzenbach and 
Schwab 2008; Schwab 2010). In addition to its source in oligodendrocytes, 
Nogo-A is expressed by neurons, especially in highly plastic areas such as 
the hippocampus, neocortex and subventricular zone / olfactory bulb system 
(Huber, Weinmann et al. 2002; Grunewald, Kinnell et al. 2009; Raiker, Lee et 
al. 2010; Rolando, Parolisi et al. 2012). Neuronal Nogo-A and its receptors 
NgR1 and Paired Ig-like Receptor B (PirB) negatively modulate functional 
synaptic plasticity (McGee, Yang et al. 2005; Syken, Grandpre et al. 2006; 
Raiker, Lee et al. 2010; Delekate, Zagrebelsky et al. 2011). Structurally, 
neutralization or ablation of Nogo-A or NgR1 increases spine turnover rate 
and density (Zagrebelsky, Schweigreiter et al. 2010; Wills, Mandel-Brehm et 
al. 2012; Akbik, Bhagat et al. 2013). Together, these studies reveal a role for 
Nogo signaling in remodeling of synaptic strength and structure and raise the 
possibility that this might affect learning and memory. However, whether the 
Nogo signaling influences learning is currently unknown. 
 
Here, we investigated the influence of Nogo-A signaling on functional and 
structural synaptic plasticity in the motor cortex and during motor learning in 
vivo. At an ultrastructural level, we confirmed the presence of Nogo-A and 
NgR1 at synaptic sites of the motor cortex. Functional neutralization of Nogo-
A increased synaptic strength, spine density of pyramidal neurons in the 
motor cortex and improved motor learning in vivo. Our results identify Nogo-A 
as an influential molecular modulator of synaptic plasticity and learning.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
Distribution and synaptic localization of Nogo-A and NgR1  
Nogo-A and NgR1 are expressed in the CNS in neurons and at synapses 
(Huber, Weinmann et al. 2002; Wang, Chun et al. 2002; Raiker, Lee et al. 
2010; Rolando, Parolisi et al. 2012). Immunostaining of cryosections of the 
adult rat motor cortex showed that Nogo-A and NgR 1 are expressed in the 
primary motor cortex (Fig. 1a, e) and were detected in layer 2/3 and 5 somata 
(Fig. 1b,c,f,g). Furthermore, Nogo-A is visible in the initial segment of the 
apical dendrites. Immunogold electron microscopy was used to further 
examine the synaptic localization of Nogo-A and NgR1. Fixed vibratome 
sections were immunostained and labeled by a secondary antibody coupled 
to a gold particle. Opposing localization of ligand and receptor was identified 
by Nogo-A immunoreactivity along the PSD (Fig. 1d) and presynaptic 
detection of NgR1 (Fig. 1h). Synaptic sites were confirmed by detection of the 
presynaptic protein vesicular glutamate transporter 1 (vGlut-1; Supplementary 
Fig. S2a) and the postsynaptic density protein 95 (PSD-95; Fig. 
Supplementary Fig. S2b).  
Taken together, these findings show juxtaposed organization of Nogo-A and 
NgR1 at synaptic sites of the motor cortex, which suggests participation of this 
system in structural and functional synaptic modifications.  
 
Functional neutralization of Nogo-A increases synaptic plasticity in the 
motor cortex 
Blockade or ablation of Nogo-A increases functional synaptic plasticity 
(Raiker, Lee et al. 2010; Delekate, Zagrebelsky et al. 2011). In the motor 
cortex, micro-RNA mediated knock-down of Nogo-A in neurons elevated LTP, 
confirming a role for the protein in activity-dependent synaptic strength (Tews, 
Schonig et al. 2013). Having observed the synaptic localization of Nogo-A, we 
next explored how its acute neutralization affects synaptic plasticity in the 
caudal primary motor cortex (M1). Fresh 500m slices containing the forelimb 
M1 area of young adult (5-6 weeks old) rats were treated for 1 hour with the 
Nogo-A specific function blocking antibody 11C7 (Oertle, van der Haar et al. 
2003; Liebscher, Schnell et al. 2005) or control antibody (mouse IgG) at a 
concentration of 5 g/ml. We determined synaptic plasticity by stimulating 
horizontal fibers in cortical layer II/III and measuring the field potential 
amplitude (FPA). LTP was induced with a TBS protocol and touch application 
of the GABAA antagonist bicuculline until saturation was reached according to 
(Rioult-Pedotti, Friedman et al. 1998; Rioult-Pedotti, Friedman et al. 2000). 
Anti-Nogo-A treated slices showed a significant increase in synaptic strength 
during the final 20 minutes of saturated LTP (Fig. 2a; 198.7 ± 22.7%, n = 14 
slices from 9 animals) compared to IgG treated control slices (142.3 ± 4.9%, n 
= 10 slices from 8 animals; p = 0.038, t-test, df: 13.9, t-value: 2.28). To test 
whether the effect of anti-Nogo upon LTP is NMDA-receptor (NMDAR)-
dependent, we blocked NMDARs with AP-5 in the presence of the anti-Nogo-
A antibody 11C7 and observed no LTP induction (Fig. 2a; n = 3 slices from 3 
animals). FPA values for the final 20 minutes after TBS application in 
presence of AP-5 were 93.74 ± 0.91. Beside the NMDAR pathway, LTP can 
be induced via decrease of inhibitory GABAergic activity (Bliss and 
Collingridge 1993). A possible role of the GABAergic system could not be 
analysed because, as shown in earlier studies (Hess, Aizenman et al. 1996) 
and confirmed here, no LTP could be induced in the motor cortex without 
reducing GABAergic inhibition by local application of bicuculline (Fig 2a; n = 6 
slices from 6 animals, 102.4 ± 2.4% during final 20 min).  
LTP is one mechanism to adapt synaptic transmission in response to external 
experience. The opposite event to synaptic strengthening is the weakening of 
neuronal connections. NgR1 is necessary for LTD induction in the 
hippocampal Schaffer collateral pathway (Lee, Raiker et al. 2008; Raiker, Lee 
et al. 2010), whereas the acute neutralization of Nogo-A does not affect LTD 
expression (Delekate, Zagrebelsky et al. 2011).  Since the influence of Nogo-
A on synaptic depression has not been investigated in the cortex yet, we 
wondered whether Nogo-A signaling affects LTD. The experimental conditions 
were identical as for LTP experiments except for the LTD protocol, which 
consisted of low-frequency stimulation (LFS; 2 Hz for 15 minutes) that was 
applied four times as described (Rioult-Pedotti, Friedman et al. 2000). 
Consistent with previous studies (Raiker, Lee et al. 2010; Delekate, 
Zagrebelsky et al. 2011), no effect was observed on LTD between anti-Nogo 
treated slices and IgG controls (Fig. 2b; 11C7: 50.9 ± 5.9%; n = 12 slices from 
10 animals; IgG controls: 55.4 ± 5.6%; n = 9 slices from 9 animals; p = 0.59; t-
test; df: 18, t-value: 0.54). Partial involvement of NMDARs in the LTD effect of 
anti-Nogo was suggested by successful LTD induction in presence of AP-5; 
however, this did not reach the level of 11C7 experiments with active 
NMDARs (Fig. 2b; 69.54 ± 2.05; n = 3 slices from 3 animals).  
The observed potentiation of synaptic responses could result from alterations 
in baseline synaptic transmission. To evaluate this possibility, we recorded 
input-output (IO) curves and found no significant differences between 11C7 
and control antibody treated slices (Fig. 2c; n = 15 vs. 15; p-value: 0.74 
(between-subjects); 2-way mixed ANOVA, df: 1; F: 0.104). The effect of anti-
Nogo-A treatment on baseline synaptic transmission was further 
characterized by analyzing the kinetics of the field response. In particular, we 
analyzed different phases of the fast component of the field response as 
indicated in Fig. 2d and found no significant difference between anti-Nogo 
treated slices and control experiments (mean values in ms for 11C7 vs. IgG 
controls for onset latency: 1.29 ± 0.23 vs. 1.57 ±0.13, p = 0.32, t = 1.02; time-
to-peak: 4.64 ± 0.37 vs. 4.42 ± 0.35, p = 0.67, t = 0.44; rise time: 0.94 ± 0.08 
vs. 0.76 ± 0.1, p = 0.18, t = 1.42; decay time: 3.59 ± 0.12 vs. 2.96 ± 0.43, p = 
0.19, t = 1.43; in all cases df = 14; two-tailed t-test). To exclude long-term 
changes in physiologic basal synaptic transmission, we measured field 
potential responses for more than 4.5 hours without adding antibodies or 
applying plasticity protocols. FPAs remained stable throughout the recording 
duration (Supplementary Fig. S1). Finally, we aimed to confirm the 
postsynaptic localization of Nogo-A with a functional readout. Paired pulse 
facilitation (PPF) is a presynaptic form of short-term plasticity characterized by 
a transient increase in presynaptic [Ca2+]i and neurotransmitter release 
induced by two closely separated stimuli (Schulz, Cook et al. 1994). We 
neutralized Nogo-A to test a possible presynaptic function and found no 
difference between 11C7 treated slices and IgG controls (Fig. 2e) indicating 
no presynaptic involvement of Nogo-A (11C7: n = 12, IgG control: n = 11; p-
value: 0.83 (between-subjects), 2-way mixed Anova, df: 1; F: 0.046).  
In summary, these results demonstrate that functional blockade of Nogo-A 
leads to an enhancement of the synaptic modification range through increase 
of LTP and consistent LTD (Fig. 2f,g). Baseline synaptic transmission, 
presynaptic properties of short-term plasticity and fast kinetics of the field 
response are not affected by anti-Nogo-A treatment. 
 
Blockade of Nogo receptor increases synaptic plasticity in the motor 
cortex 
The Nogo receptor NgR1 negatively modulates synaptic plasticity (McGee, 
Yang et al. 2005; Lee, Raiker et al. 2008; Raiker, Lee et al. 2010; Delekate, 
Zagrebelsky et al. 2011). Nep 1-40 is a 40 amino acid peptide from the 66 
amino acid extracellular loop region of Nogo-A that binds to the Nogo receptor 
and acts as a competitive antagonist for Nogo-66 (GrandPre, Li et al. 2002). 
We evaluated the impact of Nep 1-40 on synaptic strengthening at the layer 
2/3 horizontal fiber pathway in the motor cortex. Protocols for incubation and 
measurements were identical as for the anti-Nogo-A antibody experiments; 
Nep 1-40 was used at a concentration of 300 ηM. Figure 3a shows a 
significant increase (p = 0.0047, t-test; df: 15, t-value: 3.31) in the magnitude 
of LTP saturation for Nep 1-40 treated slices (176.4 ± 10.0%, n = 7 slices from 
7 animals) compared to controls (141.8 ± 6.3%, n = 9 slices from 6 animals). 
Also here, no influence of Nep 1-40 was observed on baseline synaptic 
transmission (Fig 3b, p-value: 0.48 (between-subjects), 2-way mixed Anova, 
df: 1; F: 0.509) and paired-pulse analysis (Fig 3c; n = 7 vs. 7; p-value: 0.30 
(between-subjects), 2-way mixed Anova, df: 1; F: 1.148). Next, we asked 
whether the Nogo receptor gates synaptic plasticity in the motor cortex. We 
used a function-blocking antibody against NgR1 and a goat IgG antibody as 
control at a concentration of 5 g/ml and applied identical protocols as 
described above. Treatment with functional antibodies against NgR1 yielded 
significantly higher levels of LTP saturation compared to IgG controls (Fig. 3d; 
anti-NgR1: 159.52 ± 7.79%, 8 slices from 8 animals, IgG controls: 126.45 ± 
2.07%, 10 slices from 9 animals; p = 0.0032, t-test; df: 7.8, t: 4.19). Influence 
of NgR1 signaling on baseline synaptic transmission was not observed (Fig. 
3e; anti-NgR1: n = 15; IgG: n =17; p-value: 0.94 (between-subjects), 2-way 
mixed Anova, df: 1; F: 0.004) but paired-pulse measurements revealed 
significantly higher ratios in anti-NgR1 treated slices (Fig. 3f; p-value: 0.029; 
between-subjects, 2-way mixed Anova; df: 1; F: 6.065), underlining the 
presynaptic localization of NgR1 shown in Fig. 1f.  
Thus, blockade of NgR1 increases synaptic gain without affecting baseline 
synaptic transmission and confirms the presynaptic localization of NgR1 at a 
functional level.  
 
Anti-Nogo treatment increases spine formation in vivo 
The results above identify Nogo-A and NgR1 as negative regulators of 
functional synaptic plasticity. In addition to synaptic strengthening and 
weakening, adaptations in the number and structure of synapses also 
participate in learning and memory storage processes (Holtmaat and Svoboda 
2009; Fu and Zuo 2011). Structural refinements of synaptic connections are 
influenced by Nogo-A and NgR1 (Zagrebelsky, Schweigreiter et al. 2010; 
Wills, Mandel-Brehm et al. 2012; Akbik, Bhagat et al. 2013; Mironova and 
Giger 2013). To gain insights into the significance of acute Nogo-A 
neutralization in regulating structural synaptic plasticity in the motor cortex, we 
administered anti-Nogo-A antibodies intrathecally and used in vivo 
transcranial two-photon microscopy (Xu, Yu et al. 2009) to repeatedly image 
the apical dendrites of yellow fluorescent protein expressing layer V pyramidal 
neurons (YFP-H line) (Feng, Mellor et al. 2000). Treatment with anti-Nogo-A 
antibodies 11C7 for 6 days significantly increased the amount of new spines 
added compared with mice treated with IgG control antibodies or mice without 
any treatment (Figure 4c, 11C7: 15.3 ± 4.2%, n = 4; IgG: 6.5 ± 1.2%, n = 3; 
control: 6.3 ± 0.9%, n = 4; p = 0.018, t = 3.44; df = 5, 11C7 vs. IgG; p = 0.006; 
t = 4.17; df = 6, 11C7 vs. control; p = 0.820; t = 0.24; df = 5, IgG vs. control). 
In contrast, spine elimination during the same period was comparable among 
these three experimental groups (11C7: 9.3 ± 1.1%, IgG: 10.7 ± 1.2%, control: 
10.9 ± 1.2%; p > 0.1, all pair comparisons). Together, these results show a 
negative effect of Nogo-A signaling in regulating spine number in the motor 
cortex.  
 
 
Anti-Nogo-A antibody treatment improves motor learning in vivo.  
Previous studies have identified a negative modulatory role for Nogo-A and 
NgR1 on synaptic plasticity (McGee, Yang et al. 2005; Lee, Raiker et al. 2008; 
Raiker, Lee et al. 2010; Zagrebelsky, Schweigreiter et al. 2010; Delekate, 
Zagrebelsky et al. 2011; Wills, Mandel-Brehm et al. 2012; Akbik, Bhagat et al. 
2013; Petrinovic, Hourez et al. 2013). Whether this activity of Nogo-A 
influences learning in vivo has not been investigated yet. Since changes in 
function and morphology of neuronal connections have been proposed to 
underlie motor learning (Rioult-Pedotti, Friedman et al. 1998; Rioult-Pedotti, 
Friedman et al. 2000; Rioult-Pedotti, Donoghue et al. 2007; Xu, Yu et al. 
2009; Yang, Pan et al. 2009; Yu and Zuo 2011; Fu, Yu et al. 2012), we 
wondered whether blocking Nogo-A function might improve motor skill 
acquisition in vivo. To answer this question, we exposed rats to a skilled 
forelimb-reaching task, which differed in its complexity from the classical 
reaching paradigm and forced the animal to increase the precision of the 
learned movement components (Buitrago, Ringer et al. 2004). Animals were 
trained daily over 6 days, during which they received function blocking anti-
Nogo-A (11C7) or control IgG antibodies by continuous intrathecal infusion. 
Arrival of 11C7 in the motor cortex by the applied pump implantation 
technique was described previously (Weinmann, Schnell et al. 2006) and 
confirmed here (Supplementary Fig. S3). To exclude possible effects of the 
catheter, pump or control antibody on motor learning, we trained an additional 
sham group. Figure 5b shows the success rate for the three groups. Rats 
started with low success rates on day 1 (11C7: 17.66 ± 2.65%, IgG control: 
17.59 ± 1.5%, sham: 11.27 ± 3.59%) and reached scores around 25% on the 
second session (11C7: 27.29 ± 2.66%, IgG control: 25.04 ± 2.45%, sham: 
26.67 ± 2.23%). On subsequent days, the 11C7 group showed a significantly 
steeper learning curve and reached a higher level of successful performance 
between day 4 – 6 compared to both control groups (11C7:  42.80 ± 3.34%, 
IgG: 31.45 ± 2.20%, sham: 29.10 ± 2.96% average success rates for day 4 – 
6). In total, the 11C7 group showed significantly improved motor learning 
compared to the control groups, whereas IgG controls and sham animals did 
not significantly differ in their performance (p = 0.0067; 2-way mixed Anova 
(between-subjects); 95% confidence interval = 6.99; Bonferroni corrected). 
Several lines of research suggest that motor skill acquisition consists of a 
slow phase (between training sessions) and a fast phase (within an individual 
training session) (Karni, Meyer et al. 1998; Buitrago, Schulz et al. 2004). 
Improvement in motor learning within a session was assessed by separating 
the 150 reaches per day in 25-trial bins and dividing successful scores within 
a bin by the total number of trials on the respective day (Fig. 5c). Anti-Nogo 
treated rats finished with higher scores than both control groups towards the 
end of the first two days. From day 3 on, anti-Nogo treated rats started with 
higher success rates, suggesting advanced memory consolidation and 
maintained elevated scores throughout all phases of the subsequent daily 
sessions compared to the control groups. Another form of assessing skilled 
movement acquisition is to measure the degree of precision and fine-tuning of 
the learned movement. To determine this component, we analysed 
exclusively first attempts of successfully grasped pellets in a randomly 
selected subset of the three experimental groups. In order to be counted as a 
positive first attempt, the rat had to grasp the pellet in a single monolithic 
movement execution without disruption, hesitation or repetition of the 
individual motion components. Anti-Nogo treated animals achieved 
significantly higher successful first attempt values on day 3 - 6 compared to 
IgG controls (Fig. 5d; Day 3 - 11C7: 11.33 ± 1.70%, IgG controls: 6.75 ± 
0.82%, sham: 8.67 ± 0.67%; Day 4 - 11C7: 17.42 ± 1.84%, IgG controls: 9.50 
± 1.36%, sham: 11.22 ± 0.86%; Day 5 - 11C7: 16.17 ± 2.04%, IgG controls: 
7.92 ± 1.33%, sham: 10.67 ± 0.83%; Day 6 - 11C7: 14.50 ± 1.61%, IgG 
controls: 9.00 ± 1.13%, sham: 10.33 ± 0.80%; p = 0.0089; 2-way mixed Anova 
(between-subjects); significance obtained for day 3 – 6 (p < 0.05).  
In summary, acute neutralization of Nogo-A with function blocking antibodies 
improve the acquisition of a skilled motor task. These results demonstrate a 
yet unidentified role for Nogo-A in negatively regulating motor skill learning. 
 
Anti-Nogo-A antibody treatment modulates spine density upon motor 
learning 
Finally, we questioned	 how the acute blockade of Nogo-A influences 
experience-dependent structural plasticity at motor cortex dendritic spines. 
Rats received either no infusion, a continuous intrathecal administration of 
control (IgG1) or Nogo-A function blocking antibodies while they learned a 
skilled forelimb-reaching task over 6 days. Post-learning, layer 2/3 spines in 
the forelimb region of the motor cortex were labeled by diolistics (O'Brien and 
Lummis 2007; Rauskolb, Zagrebelsky et al. 2010). As previously reported 
(Kleim, Lussnig et al. 1996; Kleim, Barbay et al. 2002), dendritic spine density 
was significantly higher in apical dendrites of the trained versus the not 
trained hemisphere (HS) of untreated control rats (sham) (Fig. 4e; sham 
untrained HS: 1.41 ± 0.05 (n = 14); trained HS: 1.59 ± 0.04 (n=13); p = 0.01; t 
= 2.754; df = 25, students t-test). In rats receiving IgG control antibodies a 
similar increase in spine density could be observed for the trained HS (Fig. 4f; 
IgG untrained HS: 1.45 ± 0.07 (n = 6); IgG trained HS: 1.65 ± 0.06 (n = 12); p 
= 0.05; t = 2.117; df = 16). Conversely, rats receiving Nogo-A blocking 
antibodies did not show increased spine density upon training (Fig. 4g; 11C7 
untrained HS: 1.64 ± 0.05 (n = 20); 11C7 trained HS: 1.72 ± 0.05 (n = 15); p = 
0.23; t = 1.223; df = 32). Interestingly, spine density in the untrained HS of 
anti-Nogo treated rats was already significantly higher than under control 
conditions (Fig. 4h; 11C7 untrained HS: 1.64 ± 0.05 (n = 20); IgG1 untrained 
HS: 1.45 ± 0.07 (n = 6); p = 0.04; t = 2.131; df = 23) resembling the result 
shown in Fig. 4c.  
In summary, spine density for the apical dendrites of layer 2/3 neurons is 
equally increased by both, anti-Nogo-A antibody treatment and training. The 
combination of anti-Nogo treatment and experience-driven plasticity results in 
indistinguishable spine density levels between trained and untrained 
hemispheres of the same animals. 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
Blockade or ablation of Nogo-A and NgR1 increases structural and functional 
synaptic plasticity (Lee, Raiker et al. 2008; Raiker, Lee et al. 2010; 
Zagrebelsky, Schweigreiter et al. 2010; Delekate, Zagrebelsky et al. 2011; 
Wills, Mandel-Brehm et al. 2012; Akbik, Bhagat et al. 2013; Petrinovic, Hourez 
et al. 2013; Tews, Schonig et al. 2013). However, it was so far not known 
whether Nogo-A signaling affects learning processes. In the present study, we 
tested the effects of Nogo-A neutralization on cortical synaptic plasticity and 
motor learning in vivo. At the ultrastructural level, we report a juxtaposed 
localization of Nogo-A and NgR1 at synaptic sites in the motor cortex. We 
show that functional blockade of Nogo-A modulates synaptic strength and 
shapes neuronal architecture by increasing spine formation and density. 
These findings are correlated with improved motor learning in vivo upon 
blockade of Nogo-A function. 
 
Synaptic influence and mechanism of action of Nogo-A 
Ablation of Nogo-A and NgR1 enhances LTP without affecting LTD (Lee, 
Raiker et al. 2008; Raiker, Lee et al. 2010; Delekate, Zagrebelsky et al. 2011). 
In this study we find that interference with Nogo-A signaling leads to 
enhancement of LTP saturation without altering maximal LTD (Fig. 2a, b). 
This change expands the limits, which determine the synaptic modification 
range within which synapses operate (Fig. 2f, g) possibly allowing a larger 
learning capacity. 
The ultrastructural analysis reveals a postsynaptic localization of Nogo-A, 
which is confirmed by the outcome of functional paired pulse measurements. 
Thus, one possibility to mediate synaptic plasticity is through cis interaction of 
Nogo-A with postsynaptic glutamate receptors (Peng, Kim et al. 2011). 
Conversely, the Nogo receptor NgR1 is identified at the presynapse both by 
the morphological and functional analysis. This opposing arrangement of 
receptor and ligand allows trans-synaptic communication of Nogo-A with 
NgR1 can influence short- and long-term synaptic changes through reverse 
signaling as suggested for Ephrin/Eph interactions (Klein 2009). As similar 
mechanisms have been suggested to underlie synaptic transmission and 
neuronal outgrowth (Llinas 1979; Schmitt 1979; Kater and Mills 1991; Bloom 
and Morgan 2011; Skucas, Duffy et al. 2013), it is intriguing to speculate that 
Nogo-A acts on synaptic function and growth processes in a similar manner 
as for axonal sprouting. A likely target of Nogo-A signaling is the actin 
cytoskeleton as it is involved in pre- and postsynaptic control of synaptic 
transmission (Dillon and Goda 2005) and shows constant rearrangement in 
response to experience-dependent synaptic plasticity (Fischer, Kaech et al. 
1998; Matus 2000). It is well known that Nogo-A mediates growth cone 
collapse through modulation of the Rho/ROCK pathway and its downstream 
effectors Lim kinase (LIMK-1) and cofilin (Montani, Gerrits et al. 2009; Nash, 
Pribiag et al. 2009). Similarly, synaptic Nogo-A may act as an upstream 
effector of this pathway to negatively regulate plasticity promoting processes 
by e.g. neurotrophic factors as suggested by the finding that NgR1 
counteracts FGF2 action on LTP (Lee, Raiker et al. 2008). A key candidate to 
link the effects of Nogo-A and neurotrophins is p75NTR as an associated 
component of the Nogo Receptor complex (Wong, Henley et al. 2002) as well 
as an affecter of the binding affinity of neurotrophins to the Trk receptor 
(Segal 2003). This pathway has been suggested to mediate negative synaptic 
plasticity (Rosch, Schweigreiter et al. 2005; Woo, Teng et al. 2005; 
Zagrebelsky, Holz et al. 2005). 
 
Nogo-A mediated changes in structural synaptic plasticity 
Long-term net changes in synaptic efficacy of the cortex can either result via 
synaptic strengthening or through changes in synapse structure and number, 
which represents an efficient way to increase the capacity for memory storage 
(Kleim, Lussnig et al. 1996; Kleim, Barbay et al. 2002; Yu and Zuo 2011). 
Newly formed spines are mostly transient and rarely survive more than a 
week (Holtmaat, Trachtenberg et al. 2005). Learning however, stabilizes 
newly formed synapses (Holtmaat, Wilbrecht et al. 2006; Hofer, Mrsic-Flogel 
et al. 2009; Xu, Yu et al. 2009). Little is known about molecular cues that 
convey stabilization of synapses. We find that synapse formation is enhanced 
with anti-Nogo treatment after 6 days (Fig. 4a-c). Similarly, increased spine 
density is observed after blockade of Nogo signaling (Fig. 4j), which, however, 
vanishes upon training-induced neuronal activity (Fig. 4k). The increase in 
synaptic plasticity through blockade of Nogo signaling may be beneficial 
during short temporal windows (minutes – weeks), whereas Nogo-A and 
NgR1 may be required to stabilize the newly formed synapses over longer 
time periods (days to weeks). In the absence of Nogo-A training-induced 
synapses are not stabilized and thus return to control levels. Sequential 
interplay between anti-Nogo-A treatment to initially increase synaptic plasticity 
and a later Nogo-A action to stabilize newly formed connections may be a key 
concept to efficiently exploit the potential of this concept. 
 
Nogo-A affects motor learning in vivo 
Since LTP and LTD have been suggested as cellular correlates for learning 
and memory and improvement of the learned motor skill is accompanied by 
changes in synaptic strength (Rioult-Pedotti, Friedman et al. 1998; Rioult-
Pedotti, Friedman et al. 2000), synapse formation (Xu, Yu et al. 2009) and the 
synaptic modification range (Rioult-Pedotti, Friedman et al. 2000; Rioult-
Pedotti, Donoghue et al. 2007), we hypothesized that enhancement of 
structural and functional synaptic plasticity enlarges the memory capacity per 
synapse to improve motor learning in vivo. In the present study, we have 
identified Nogo-A as a molecular player, which negatively regulates synaptic 
plasticity and motor learning. Interestingly, whereas short-term interference 
with Nogo-A leads to improved learning, chronic inhibition of Nogo-A in 
combination with activity over several weeks has been shown to result in 
negative outcomes of the learned task (Maier, Ichiyama et al. 2009; Starkey 
and Schwab 2012). In line with this concept, interference with NgR1 has been 
reported not to affect short-term memory but to impair long-term memory 
(Karlen, Karlsson et al. 2009). Whereas acutely interfering with Nogo-A 
facilitates synaptic plasticity and motor learning in a short temporal window, 
chronic application of Nogo-A antibodies in vivo may overload the system via 
a coherent increase of structural and functional plasticity. A challenging 
assignment for future studies is to determine the optimal window and 
sequential strategy during which beneficial features of anti-Nogo-A treatment 
are exploited for CNS regeneration without disturbing basic neuronal 
functioning. 
 
Potentials for CNS Regeneration 
Activity-dependent plasticity is a crucial driving force to enhance functional 
regeneration after CNS injury (Maier, Ichiyama et al. 2009). Nogo-A and 
NgR1 are both downregulated in sensory-motor areas during increased 
activity (Josephson, Trifunovski et al. 2003; Ghiani, Ying et al. 2007), 
indicating that the Nogo system needs to be decreased physiologically in 
order to release the brakes and allow plastic changes. Absence of Nogo-A 
ameliorates this process and thus may increase the potential for CNS 
regeneration. Selective and sequential enhancement of this strategy may be 
used to gain clinical benefit and behavioral advantage after CNS injury. 
Furthermore, the use of function blocking antibodies is a promising clinical 
feature. Whereas Nogo-A KO mice and knock-down rats show 
neuropsychiatric phenotypes (Willi, Weinmann et al. 2010; Tews, Schonig et 
al. 2013), antibodies against Nogo-A are well tolerated (Willi, Weinmann et al. 
2010). Our result in Fig. 2d indicates that basic neuronal functioning is not 
disturbed by anti Nogo-A antibodies.   
In summary, we identify Nogo-A and NgR1 at synaptic sites in the motor 
cortex and show that functional blockade of Nogo-A enhances synaptic gain 
through strengthening of connections, formation of new synapses and an 
overall increase of the synaptic modification range. These changes are 
accompanied by improvement of motor learning in-vivo during treatment with 
the Nogo-A antibody 11C7. The relevance of this mechanism for functional 
recovery and rehabilitation after CNS injury remains to be investigated. 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS & METHODS 
 
Up to 3000 words 
 
Animals. Adult male Sprague Dawley rats (5-6 weeks, 190-220g, Janvier) 
were used for LTP, LTD, in vivo motor learning and electron microscopy (EM) 
experiments. They were housed in standard cages in groups of three animals 
per cage, in a reversed light/dark cycle (light on 8:00 P.M., light off 8:00 A.M.). 
All experiments were conducted with the approval of the Veterinarian Office 
Zurich, Switzerland and in accordance with their guidelines. Thy1-YFP-H line 
mice (Feng, Mellor et al. 2000) were purchased from Jackson Laboratory for 
in vivo imaging of dendritic spines. Mice were housed and bred in University 
of California Santa Cruz (UCSC) animal facilities according to approved 
animal protocols. 
 
Immuno Electron Microscopy. For pre-embedding immunolocalization of  
PSD-95, VGlut-1, Nogo-A and NgR1, 40μm thick coronal cryostat sections  
were prepared from M1 layer 2/3, treated with 0.5% NaBH4 in tris buffer 
saline (TBS) for 10 min and in tris glycin 50mM (pH 8.0) for 30 min to quench 
the free aldehyde groups. After passing freeze and thaw cycles to enhance 
the permeability, sections were rinsed several times in TBS and incubated for 
2 days with the primary antibody (PSD-95, 1:200; VGlut1, 1:500; Nogo-
A/Laura, 1:200; NgR1, 1:100) at 4°C on a shaker. Exposition to biotinylated 
secondary antibody (1:200; Jackson Immuno Research) was followed by 
Streptavidin Peroxidase ABC Elite Kit (1:100; Vector). Sections were 
subsequently incubated with 0.025% 3,3′-diaminobenzidine tetrahydrochloride 
(DAB) in the presence of 0.006% H2O2 for 5 - 10 min. DAB staining was 
intensified by the methenamine silver-gold reaction according to 
(Teclemariam-Mesbah, Wortel et al. 1997; Petrinovic, Hourez et al. 2013). 
Compared to the conventional DAB product, the high electron density of gold-
substituted DAB-silver grains facilitates ultrastructural recognition of stained 
structures. Sections were osmicated and after uranyl acetate contrast 
incubation embedded in epoxy. Ultrathin sections of 100nm were analyzed in 
a Zeiss EM10 electron microscope. Synaptic sites were identified by detection 
of the described presynaptic marker vesicular glutamate transporter 1 (v-
Glut1) and the postsynaptic marker PSD-95 (El Mestikawy, Wallen-Mackenzie 
et al. 2011; Sun and Turrigiano 2011). 
 
Blocking reagents. For ex-vivo slice physiology, four different highly purified 
mouse and goat monoclonal antibodies were used: A Nogo-A specific 
blocking antibody (11C7), raised against an 18-aa peptide in the most active 
region of NogoA (Nogo∆20, a gift from Novartis Pharma AG, Basel, 
Switzerland) and shown to block the Nogo-A mediated neurite outgrowth 
inhibition in vitro and in vivo (Oertle, van der Haar et al. 2003; Liebscher, 
Schnell et al. 2005; Maier, Ichiyama et al. 2009), a control antibody (mouse 
IgG), an antibody against the Nogo receptor subunit NgR1 (mNogo receptor 
affinity-purified goat IgG; R&D Systems) and a goat IgG control antibody 
(R&D Systems). Antibody solutions were freshly prepared in carbogenated 
ACSF at a final concentration of 5 μg/mL. To prevent sticking of the antibody 
to the tubing and the chamber, silicon tubing was used and washed with 
ACSF containing BSA (0.1 mg/mL). The slices were pre-incubated for 1 h with 
the anti-Nogo-A, anti-Nogo Receptor or respective control antibodies in an 
incubation chamber maintaining a constant flow of the solution. The Nogo-66 
(1-40) antagonist peptide (Nep1-40) was used at a concentration of 300nM. 
For in-vivo experiments, the above-mentioned NogoA-specific blocking 
antibody 11C7 and mouse IgG control antibody were used at a concentration 
of 3.0 – 4.2 mg/ml. To exclude possible effects of the catheter, pump or 
control antibody on motor learning, we trained an additional sham group. 
Animals belonging to this group received identical steps of the surgical 
protocol as the two antibody groups but no pump-implantation. 
Slice Preparation. Coronal slices containing the forelimb area of M1 (1-2mm 
anterior to the bregma; Donoghue and Wise 1982), were prepared from adult 
Sprague Dawley rats (180-220 g) as previously described (Hess, Aizenman et 
al. 1996; Rioult-Pedotti, Friedman et al. 1998). Animals were anesthetized by 
intra-peritoneal injection of pentobarbital. After decapitation, the brain was 
removed quickly and coronal slices, ~500μm thick, were cut using a vibratome 
(Leica VT 1000S, Leica Biosystems, Nussloch, Germany). 
Electrophysiological Recordings. Slices were transferred to a fluid-gas 
interface chamber and superfused at a constant rate of 1ml/min with ACSF 
(composition in mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 26 NaHCO3, 1MgSO4, 
2CaCl2 and 10 glucose, bubbled with a 95% O2, 5% CO2 mixture at 33 ± 
0.5°C). The humidified atmosphere over the slices was saturated with 95% 
O2 and 5% CO2. Slices were left in the chamber to recover for at least 1 hour 
after dissection. To allow optimal antibody penetration, responses were 
recorded from the slice surface of layer II/III within the motor cortex. For all 
experiments, measurements were obtained as previously described (Rioult-
Pedotti, Friedman et al. 1998; Rioult-Pedotti, Friedman et al. 2000). For LTD 
experiments, low-frequency stimulation (LFS) was induced four times 
(referred to as maximum LTD), all other protocols were identical to (Rioult-
Pedotti, Friedman et al. 1998; Rioult-Pedotti, Friedman et al. 2000) 
For data analysis, we computed the amplitude of the field potential response 
because it serves as a measure of the population excitatory synaptic 
response (Rioult-Pedotti, Friedman et al. 1998; Rioult-Pedotti, Friedman et al. 
2000), reflects a monosynaptic current sink (Hess, Aizenman et al. 1996) and 
correlates well with the intracellular excitatory postsynaptic response evoked 
in this pathway (Aroniadou and Keller 1995). Measurement of the field 
potential slope, as routinely used, e.g., in the hippocampus, has not been 
used for neocortical field potential responses due to the interference of the 
response’s initial part by variable non-synaptic components (Hess and 
Donoghue 1994).  
Presynaptic properties were investigated through paired pulse measurements, 
which were performed by applying a pair of two stimuli in different 
interstimulus intervals (ISI) in a range of 10, 20, 40, 80 and 160 ms. The 
amplitude of the second response was divided by the amplitude of the first 
response. The result was expressed as the paired pulse ratio (PPR). 
Analysis of Kinetics. The kinetics of the field response were characterized 
by rise time, decay time, and width at half maximum. The rise time r was 
estimated from the 30/70 time (the time it takes the signal to transition from 
30% to 70% of its maximal value or peak amplitude). Decay time constants 
were estimated by fitting the decaying phase of the field to a sum of two or 
three decaying exponentials (Levenberg-Marquardt non-linear least squares). 
Decay time d reported in the results section refers to the fastest decay time 
constant obtained by the fitting. The onset of the field response was further 
characterized by its onset latency and time to peak. The onset latency was 
obtained as the time interval between the stimulation and response onsets 
(the latter estimated from the intercept of a line fitting of the rising phase of the 
field response with the baseline immediately before the stimulation). The time 
to peak was determined as the time interval between stimulation onset and 
the field response maximum. All time constants were obtained individually for 
a total of 1148 trials corresponding to n = 16 slices (8 treated with anti-Nogo 
and 8 controls). For each slice the median across trials was computed to 
reduce the effects of outliers. Each group was finally described by the mean 
of the individual medians.  
Data Analysis Electrophysiology. Experimental data were collected with 
LabView software (National Instruments) and analyzed with LabView, Matlab 
(MathWorks), Graphpad Prism (Graphpad software) and Excel (Microsoft). 
Horizontal fibers in layer 2/3 of the motor cortex were stimulated and the 
amplitude of elicited fEPSPs was measured over time, normalized to baseline 
values and plotted as average ± SEM.  
Intrathecal pump implantation. Animals were anesthetized with a 
subcutaneous injection of Hypnorm (120μl/200gm body weight; Janssen 
Pharmaceutics, Beerse, Belgium) and Dormicum (0.75mg in 150μl per 200gm 
body weight; Roche Pharmaceuticals, Basel, Switzerland). Vitamin A–
containing eye ointment was applied to protect the eyes from dehydration 
during the procedure. After partial laminectomy at T3 vertebral level, a fine 
intrathecal catheter (32G, Recathco) was inserted into the subarachnoid 
space from the lumbar level L2/L3 and pushed rostrally to the spinal segment 
C7, delivering the antibodies from an osmotic minipump (10μl/h, Alzet 2ML1, 
Alzet Osmotic Pumps, Cupertino, CA) into the CSF for 7 days as previously 
described (Weinmann, Schnell et al. 2006; Willi, Weinmann et al. 2010). 
Analgesics (Rimadyl; Pfizer AG, Zürich, Switzerland) were given post-
operation by subcutaneous injection. The antibiotic Baytril (5mg/kg body 
weight, SC; Bayer AG, Leverkusen, Germany) was administered once a day 
for 2 days starting on the day of operation to prevent bladder infections. Sham 
animals received all surgical steps and medications except for pump 
implantation. 
 
In Vivo Transcranial Imaging and Data Quantification. YFP-H line mice of 
both sexes at one month of age were used in all the experiments. The surgical 
procedure for transcranial two-photon imaging and data quantification have 
been described previously (Xu, Yu et al. 2009). Intrathecal pumps were 
implanted as described above immediately following the first time images. The 
second time images were obtained 6 days later.  Percentages of eliminated 
and formed spines were normalized to total spines counted in the first images. 
 
Motor Skill Learning. Animals were handled to get accustomed to the 
experimenter and the housing environment and were food-restricted for 24 h 
prior to the first pre-training session. During pre-training and training, animals 
were kept on a standard laboratory diet to maintain their initial weight (187.8 ± 
3.29 g). Water was given ad libitum.  Training was performed in a plexiglas 
box (34 × 14 cm) with a vertical window opening, which allowed the animal to 
retrieve the food pellet. During pre-training, pellets were close enough to be 
reached with the animal’s tongue. The animal had to learn to run to the rear of 
the cage in order to access the next pellet at the slit opening. This task 
allowed the rat to reposition prior to each pellet retrieval. Once >=50 trials of 
pellets were eaten with the tongue in less than 15 minutes, animals 
underwent surgery to receive osmotic pumps 16 - 24 h after the last pre-
training session. During pre-training, animals did not retrieve food pellets with 
their forelimb. 48 hours after the pump implantation animals were exposed to 
the first motor learning session. For the forelimb-reaching task, the pellet 
board was replaced by a vertical pedestal, on which the pellets were placed at 
a distance (1.5 cm) at which they could only be retrieved by the rat’s forelimb. 
During the first 10 trials forelimb preference was determined by positioning the 
pedestal at the center of the cage’s vertical slot. The pedestal was then 
shifted contrary to the rat’s preferred forelimb to allow an optimal reaching 
angle with the preferred forelimb and remained in that position throughout all 
remaining trials. The diameter of the pedestal corresponded to that of the 
pellet, thus, pellets were discarded from the post easily. For a successful 
grasp, pellets had to be retrieved by a precise, skilled forelimb movement 
composed of stretching the forelimb toward the box window and pellet, 
targeting the pellet, pronation, opening of the paw, grasping, pulling the 
forelimb back while supinating, retrieving the pellets successfully and eating 
them (Whishaw and Pellis 1990). A trial, defined as a new pellet presented to 
the animal was classified as “successful” (reach, grasp, retrieve and eat the 
pellet), drop (reach, grasp and lose pellet during retrieval) or “fail” (discard 
pellet from the pedestal). A daily session consisted of 150 trials or a maximum 
time of 1 hour for each animal. The success rate of each daily session 
(between training sessions) was calculated as the sum of successfully 
retrieved pellets divided by the total number of trials. Except for the first day of 
training, no animal reached the maximum time but completed 150 trials in less 
than an hour. Sessions lasted on average 23.2 ± 1.38 min. To analyse the 
performance during each daily session (within session analysis), we divided 
the 150 trials into 25 trial bins and calculated the percentage of successfully 
grasped pellets for each bin by dividing the number of successes in the 
respective bin by the total number of trials on the respective day. Precision 
and fine-tuning of the movement were investigated through first attempt 
analysis in a subset of animals: First attempts were considered positive when 
the animal grasped the pellet in a single monolithic movement execution 
without disruption, hesitation or repetition of individual movement 
components. All experiments were performed in a double-blind manner: 
animals were coded with random numbers and the groups were mixed within 
the cages. Experimenters were blind to the treatments throughout all phases 
of the experiment until completion of data analysis.   
 
Statistical Analysis. For in-vivo motor skill learning, two-way mixed analysis 
of variance (ANOVA) (between-subjects factor: group of treatment; within-
subjects factor: day of training) was applied. If a significant effect was found 
for a factor, post hoc tests were performed using Bonferroni correction for 
multiple comparisons. For all other experiments, two-sampled, two-tailed t-
tests with unequal sample size were used. Normality and equal variance 
hypotheses were tested by Kolmogorov-Smirnov test and F-test, 
respectively.  All values in the results section are given as mean ± SEM. 
 
Diolistics and dendritic spine imaging in fixed tissue. Coronal slices 
containing the forelimb area of M1 were prepared as for electrophysiological 
experiments.  The slices were fixed in 4% PFA overnight at 4°C and washed 
with 1x Phosphate Buffered Saline (PBS). The Diolistic was performed as 
previously described (Rauskolb, Zagrebelsky et al. 2010). Dye-coated 
particles were delivered to the coronal slices using a hand held gene gun 
(Bio-Rad; Helios Gene Gun System) and kept in PBS for 3 days for the dye to 
diffuse. The slices were postfixed in 4% PFA, washed and stained with DAPI 
to enable the identification of the cortical layers. Layer 2/3 neurons from the 
forelimb area of M1 were imaged with a BX61WI FLUOVIEW 1000 (FV1000) 
Olympus confocal microscope. Image stacks of defined dendritic stretches 
from the mid-apical dendritic parts were acquired using a 40x oil objective 
(NA1.3), z-step of 0.5µm and a zoom of 4. 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURES 
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Fig. 1: Distribution and synaptic localization of Nogo-A and NgR 1 in the 
motor cortex. (a-c) Immunostaining with anti-Nogo-A revealed expression of 
the protein in cell bodies of layer 2/3 and 5 of the motor cortex. (e-g) NgR1 
was detected in layer 2/3 and 5 somata. (d, h) Nogo-A and its receptor NgR1 
are complementary expressed. Strong immunolocalization of Nogo-A is 
observed in the postsynaptic density, whereas NgR1 labeled immunogold 
particles are identified in presynaptic terminals.  
 
 
Fig. 2: Functional blockade of Nogo-A increases synaptic plasticity in 
the rat primary motor cortex. Slices from the forelimb region of the rat 
primary motor cortex were treated with the functional Nogo-A blocking 
antibody (Ab) 11C7 (green) or control Ab (orange). Insets show representative 
field potential (FP) waveforms obtained from layer II/III horizontal fibers taken 
at time points indicated by numbers in each figure. Up arrows: LTP induction, 
down arrows: LTD induction. (a) During the last 20 minutes of saturated LTP, 
a significant difference between 11C7-treated and IgG control treated slices is 
observed (p < 0.05; t-test). LTP induction in 11C7 treated slices fails in 
presence of NMDA antagonist AP-5 (grey). No LTP is induced in 11C7-
treated slices in absence of bicuculline (blue). (b) LTD shows no obvious 
difference between the 11C7 and control group for the last 20 minutes of 
maximal LTD (p > 0.05, t-test). LTD is successfully induced in 11C7-treated 
slices in presence of NMDA antagonist AP-5. (c,e) Input-output strength and 
paired pulse measurements revealed no significant differences between 
11C7-treated slices and IgG controls. (d) Kinetics of the fast component of the 
field response (FR). The rise time τL, time-to-peak τP, rise time τR and decay 
time τD of the field response (FR) kinetics were characterized. No significant 
difference is seen between anti-Nogo and control antibody treated slices. 
Inset illustrates phases of the field response used for analysis. (f,g) 
Expansion of the synaptic modification range. The space between LTP and 
LTD saturation is defined as the “synaptic modification range”. Treatment with 
anti-Nogo expands LTP saturation (98%) without altering LTD and by this 
leads to an enlarged range. 
 
Fig. 3: Blockade of the Nogo receptor enhances long-term potentiation 
in the rat primary motor cortex. Slices from the M1 forelimb region were 
treated with the Nogo-66 (1-40) antagonist peptide Nep1-40 and a functional 
antibody against NgR1. Insets show representative field potential waveforms 
taken at time points indicated by numbers in each figure. Up arrows: LTP 
induction, down arrows: LTD induction. Protocols were identical as in Fig. 2. 
(a-c) During the last 20 minutes of saturated LTP, a significant difference 
between Nep 1-40-treated slices (red) and controls (grey) is observed (p < 
0.005; t-test). Input-output strength and paired pulse analysis revealed no 
significant differences between Nep 1-40 treated slices and controls. (d-f) 
During the last 20 minutes of saturated LTP, a significant difference between 
anti-NgR1-treated (blue) and IgG control treated slices (grey) is observed (p < 
0.005; t-test). Input-output strength revealed no significant difference between 
anti-NgR1-treated slices and IgG controls. Paired pulse analysis reveals 
significantly higher ratios for anti-NgR1 treated slices in comparison to IgG 
controls (p < 0.05). 
 
Fig. 4: Functional blockade of Nogo-A increases spine formation in vivo. 
(a,b) Representative images of in vivo imaging in mice. Repeated imaging of 
the same dendritic branches over six-day intervals in the motor cortex in 
animals treated with	 treated with IgG control antibodies (a) or Anti-Nogo 
antibodies (b). Arrows represent newly formed spines. Scale bar represents 
2μm. (c) Quantified percentage of spine formation and elimination in 
untreated (grey), IgG control antibody treated (orange) and anti-Nogo treated 
animals (green).  
 
Fig. 5: Anti-Nogo-A antibody treatment improves motor learning in vivo. 
Rats were exposed to a complex precision forelimb reaching task while 
receiving anti-Nogo-antibodies (11C7; green), IgG control antibodies (orange) 
or no antibody treatment (sham, grey). (a) Experimental procedure. (b) Motor 
skill acquisition over six days. 11C7 treated animals show significantly 
improved motor learning compared to IgG control treated and sham animals 
(p < 0.05; 2-way mixed Anova). No significant difference was observed 
between IgG controls and sham animals (p > 0.05; 2-way mixed Anova). (c) 
Within-day success rates illustrate improvement in motor learning throughout 
a single session. Anti-Nogo treated animals finish with higher scores towards 
the end of the first two days and reach higher success rates throughout all 
phases between day 3 - 6. (d) First attempts are shown as a measure for fine 
tuned movement learning. 11C7 receiving animals shows significantly higher 
first attempt values on day 3 - 6 compared to IgG controls (p < 0.05; 2-way 
mixed Anova, Bonferroni correction).  
 
Fig. 6: Anti-Nogo-A antibody treatment affects spine density upon motor 
learning. (a-d) Representative images of the apical dendritic regions labeled 
with DiI, comparison of the trained versus untrained hemisphere for sham 
control vs. Nogo-A blocking antibodies (11C7). Scale bar represents 2μm. (e-
h) Quantified data showing dendritic spine density for the apical dendrites in 
the trained versus untrained hemisphere in sham animals, IgG control 
antibody treated animals and 11C7 treated animals. (k) Quantification 
showing spine density for the untrained hemisphere of IgG control vs. 11C7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUPPLEMENTARY FIGURES 
 
Fig. S1: Long-term baseline recording (280 min). (a) Slices from the M1 
forelimb region were prepared and baseline was recorded over 4.5 hours as a 
negative control to evaluate possible long-term changes in baseline levels. 
 
Fig. S2: Confirmation of synaptic sites in the rat layer 2/3 motor cortex. 
(a, b) Labeling of presynaptic vGlut-1 and postsynaptic PSD-95 markers were 
used to confirm synaptic sites in the rat motor cortex layer 2/3. 
 
Fig. S3: IgG antibody uptake in the motor cortex. (a) Relative optical 
density measured in slices from the motor cortex. Anti-Nogo antibodies show 
22% higher mean grey values compared to control mouse IgG. (b) 
Representative image taken from adult rat motor cortex. 
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